Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases
- 1 September 2005
- journal article
- review article
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 24 (5), 587-611
- https://doi.org/10.1016/j.preteyeres.2005.01.004
Abstract
No abstract availableKeywords
This publication has 170 references indexed in Scilit:
- Triamcinolone acetonide concentration after filtration of the solvent agentAmerican Journal of Ophthalmology, 2005
- Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonideAmerican Journal of Ophthalmology, 2004
- Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonideAmerican Journal of Ophthalmology, 2004
- Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's diseaseAmerican Journal of Ophthalmology, 2004
- Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet diseaseAmerican Journal of Ophthalmology, 2004
- Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injectionAmerican Journal of Ophthalmology, 2004
- Intravitreal triamcinolone acetonide for the management of diabetic papillopathyAmerican Journal of Ophthalmology, 2004
- Cytotoxicity of Triamcinolone on Cultured Human Retinal Pigment Epithelial Cells: Comparison with Dexamethasone and HydrocortisoneJapanese Journal of Ophthalmology, 2004
- Intraocular availability of triamcinolone acetonide after intravitreal injectionAmerican Journal of Ophthalmology, 2004
- The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularizationAlbrecht von Graefes Archiv für Ophthalmologie, 1993